Markntel Advisors’ report, Type-2 Diabetes Research Report: Trend, Business Growth, Size, Future Scope, Segmentation, Dynamics, and Forecast to 2028, offers a comprehensive guide for the growing industry. The expert team of analysts dedicated significant effort to gathering and evaluating the latest market data, resulting in a detailed and up-to-date report that offers valuable insights for individuals who rely on data-driven decisions, including business owners and analysts. The research report on the Type-2 Diabetes presents well-researched facts and figures pertinent to the industry, whether the goal is to explore new markets, launch a new product, or maintain a competitive advantage.
Type-2 Diabetes Market Research Report & Market Summary:
The Global Type-2 Diabetes Market is projected to grow at a CAGR of around 8.0% during the forecast period, i.e., 2023-28. The market growth is favorably fostered by the increasing prevalence of type 2 diabetes stemming from unhealthy lifestyles, physical inactivity, and obesity. According to WHO, around 422 million people worldwide have diabetes, out of which the majority live in low-and middle-income countries. In addition, diabetes accounts for more than 1.5 million deaths each year. The number of cases and the prevalence of diabetes have witnessed expansion over the past few decades. In addition, the rising geriatric population, along with the surging population with type-1 diabetes and the lack of proper healthcare infrastructure in emerging countries, are projected to boost the growth of the type-2 Diabetes market globally in the forthcoming years.
✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
If you’re interested in the assumptions considered in this study, you can download the PDF brochure- https://www.marknteladvisors.com/query/request-sample/global-type-2-diabetes-market.html
Type-2 Diabetes Market Segmentation Analysis:
According to MarkNtel study the market is segmented into the following categories:
By Drug Type
- Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
- Alpha-glucosidase Inhibitors
- Biguanides
- Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
- Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2)
- Sulfonylureas
- Other (Thiazolidinediones, Meglitinides, Glitazones, etc.)
By Gender
- Male
- Female
Between the two, the Women segment held a significant market share in the Global Type-2 Diabetes market in 2022, owing to the alarming rise in the prevalence of type-2 diabetes among pregnant women. Due to multiple adverse pregnancy outcomes, the development of gestational diabetes is high among pregnant women. Besides, the chance of developing type 2 diabetes is higher, especially three to six years after delivery.
By Age Group
- Upto 19 years
- 20 – 65 years
- Above 65 years
By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia-Pacific.
Here, North America captured a considerable market share in the Global Type-2 Diabetes market in 2022, with The US acquiring the majority market share in the region. It primarily attributes to the surge in the rate of obesity, cardiovascular, and chronic diseases in the country, which has proliferated the growth of type-2 diabetes in people. According to the Centers for Disease Control and Prevention, diabetes negatively impacts around 37 million Americans, with type 2 diabetes accounting for 90-95% of cases.
As indicated in the latest market research report published by Markntel Advisors, “Type-2 Diabetes Research Report: Forecast (2023-2028)”, this report offers a detailed analysis of the industry, featuring insights into the Type-2 Diabetes industry. It encompasses competitor and geographical analyses, as well as recent advancements in the market.
Browse Full Report Along with TOC and Figures – https://www.marknteladvisors.com/research-library/global-type-2-diabetes-market.html
Top Companies Operating in the Type-2 Diabetes Market:
- Merck & Co
- AstraZeneca
- Novo Nordisk
- Bristol-Myers Squibb
- Eli Lilly
- Sanofi
- Boehringer Ingelheim
- Pfizer
- Takeda
- Biocon
- Johnson & Johnson.
*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address*
Other Report:
- https://tach-amit.blogspot.com/2025/01/female-technology-market-2023-2030-size.html
- https://tach-amit.blogspot.com/2025/01/aseptic-packaging-for-food-and-beverage.html
- https://tach-amit.blogspot.com/2025/01/data-science-platform-market-trends.html
- https://tach-amit.blogspot.com/2025/01/eastern-europe-core-banking-market-2023.html
- https://tach-amit.blogspot.com/2025/01/europe-electric-bus-market-innovations.html
Key Report Highlights:
- Market Dimensions & Projections
- Pricing Evaluation,
- Recent Strategic Moves by Companies,
- Primary Stakeholders,
- Analysis of Import and Export Trends,
- Competitive Landscape Assessment,
- Emerging Opportunities,
- Market Trends and Indicators
Note – If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.
Frequently Asked Questions (FAQs)-
- What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
- What are the trends influencing the current scenario of the market?
- What leading factors would propel and impede the industry across the geography?
- How has the industry been evolving in terms of geography & Type-2 Diabetes Market adoption?
- How has the competition been shaping up across the geography?
- Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?
About Us –
We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Call + +1 628 895 8081, +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
Leave a Reply